Assessing the Effectiveness of Valbenazine in the Treatment of Tardive Dyskinesia as Determined by the AIMS and PGIC: Results from the KINECT 4 Trial

被引：0
|
作者：
Singer, C.
Comella, C.
Farahmand, K.
Burke, J.
Jimenez, R.
Siegert, S.
机构：
来源：
MOVEMENT DISORDERS | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
70
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [21] GLOBAL IMPROVEMENTS IN TARDIVE DYSKINESIA AND PATIENT SATISFACTION WITH VALBENAZINE IN OLDER AND YOUNGER PATIENTS: RESULTS FROM AN OPEN-LABEL, ROLLOVER STUDY
    Sajatovic, Martha
    Lindenmayer, Jean-Pierre
    Burke, Joshua
    Jimenez, Roland
    Farahmand, Khodayar
    Siegert, Scott
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : S175 - S175
  • [22] Global Improvement and Patient Satisfaction: Results from a Long-Term, Open-Label, Rollover Study of Valbenazine in Tardive Dyskinesia
    Lessig, S.
    Marder, S.
    Verghese, C.
    Burke, J.
    Jimenez, R.
    Siegert, S.
    Liang, G.
    MOVEMENT DISORDERS, 2018, 33 : S40 - S40
  • [23] Efficacy and safety of tetrabenazin in treatment of tardive dyskinesia results of a multicentric non-interventional trial
    Dose, Matthias
    Gawora, Karin
    PSYCHOPHARMAKOTHERAPIE, 2009, 16 (05): : 203 - +
  • [24] Valbenazine in Tardive Dyskinesia of Older and Younger Adults: Pooled Results From 3 Randomized, Double-Blind, Placebo-Controlled Trials
    Sajatovic, Martha
    Alexopoulos, George
    Farahmand, Khodayar
    Sheth, Bijal
    Burke, Joshua
    Siegert, Scott
    Liang, Grace
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S572 - S573
  • [25] Effects of long-term valbenazine in patients with tardive dyskinesia and a primary mood disorder: Results from an open-label, rollover study
    McIntyre, Roger
    Marder, Stephen
    Verghese, Cherian
    Shah, Chirag
    Farahmand, Khodayar
    BIPOLAR DISORDERS, 2020, 22 : 109 - 109
  • [26] Effects of Valbenazine on Prolactin in Adults With Tardive Dyskinesia: Pooled Results From 3 Randomized, Double-Blind, Placebo-Controlled Trials
    Grigoriadis, Dimitri
    McIntyre, Roger
    Siegert, Scott
    Dao Thai-Cuarto
    Burke, Joshua
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S207 - S207
  • [27] Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia: Results of Long-Term Exposure Data from Three Studies
    Remington, Gary
    Factor, Stewart
    Comella, Cynthia
    Liang, Grace
    Burke, Joshua
    O'Brien, Christopher
    NEUROLOGY, 2017, 88
  • [28] Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia: Results of Long-Term Exposure Data From Three Studies
    Remington, Gary
    Comella, Cynthia
    Grigoriadis, Dimitri
    Liang, Grace
    Burke, Joshua
    O'Brien, Christopher
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S212 - S213
  • [29] LONG-TERM EFFECTS OF VALBENAZINE ON TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA/SCHIZOAFFECTIVE DISORDER: RESULTS FROM AN OPEN-LABEL, ROLLOVER STUDY
    Kane, John
    Marder, Stephen
    Lindenmayer, Jean-Pierre
    Jimenez, Roland
    Farahmand, Khodayar
    Siegert, Scott
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S199 - S200
  • [30] Treatment of tardive dyskinesia by pallidal stimulation: Results from the French multicenter study STARDYS
    Damier, P
    Thobois, S
    Witjas, T
    Derkinderen, P
    Xie, J
    Azulay, JP
    Broussolle, E
    Burbaud, P
    Durif, F
    Rascol, O
    NEUROLOGY, 2004, 62 (07) : A504 - A504
12345